• LAST PRICE
    6.6100
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    6.6200/ 7
  • Ask / Lots
    6.6300/ 9
  • Open / Previous Close
    6.1400 / 6.6100
  • Day Range
    Low 5.9660
    High 6.8522
  • 52 Week Range
    Low 1.3250
    High 6.8522
  • Volume
    294,643
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 6.12
TimeVolumeBIVI
09:32 ET41996.14
09:37 ET13405.966
09:39 ET10006.1307
09:44 ET9006.0277
09:46 ET10006.08
09:48 ET10706.1399
09:50 ET39396.14
09:51 ET11006.14
09:53 ET62346.15
09:57 ET3006.245
10:00 ET11006.2499
10:02 ET54506.2001
10:04 ET30006.2001
10:06 ET19006.2215
10:08 ET2006.2
10:11 ET78646.4
10:13 ET13886.35
10:15 ET65506.43
10:18 ET72666.47
10:20 ET77386.605
10:22 ET6006.615
10:24 ET19086.55
10:26 ET51006.4535
10:27 ET129986.455
10:29 ET81006.3881
10:31 ET31006.34
10:33 ET23606.495
10:36 ET49406.495
10:38 ET16006.49
10:40 ET109116.62
10:42 ET358196.81
10:44 ET76716.71
10:45 ET54696.72
10:47 ET218076.54
10:49 ET30306.6309
10:51 ET66076.575
10:54 ET48506.49
10:56 ET19356.5013
10:58 ET6006.4501
11:00 ET71996.485
11:02 ET22006.52
11:03 ET16006.5
11:05 ET8736.55
11:07 ET1006.6065
11:12 ET13006.5601
11:14 ET15506.5659
11:16 ET8566.6234
11:18 ET16976.55
11:20 ET1006.53
11:21 ET3006.56
11:23 ET29006.5371
11:25 ET7006.485
11:27 ET6396.46
11:30 ET5086.4475
11:32 ET34516.34
11:34 ET11966.3782
11:36 ET1006.39
11:41 ET5006.4413
11:43 ET1006.395
11:48 ET4206.4484
11:50 ET1006.415
11:52 ET3006.3884
11:59 ET4006.5175
12:01 ET12006.481
12:06 ET10006.475
12:08 ET29006.4999
12:10 ET9576.56
12:14 ET26986.63
12:15 ET1006.565
12:17 ET2506.5989
12:19 ET1006.576
12:21 ET11866.61
12:24 ET10006.6482
12:26 ET3006.65
12:28 ET41126.6999
12:30 ET36326.61
12:33 ET15256.66
12:35 ET2006.65
12:37 ET1006.625
12:39 ET19006.5801
12:42 ET67826.5175
12:44 ET3006.5
12:46 ET1006.53
12:48 ET10506.535
12:50 ET60936.5499
12:51 ET2006.58
12:53 ET29006.5999
12:55 ET15006.5765
12:57 ET9196.6326
01:00 ET40866.61
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesBIVI
BioVie Inc
201.8M
-5.5x
---
United StatesTCRT
Alaunos Therapeutics Inc
200.2M
-4.9x
---
United StatesGRPH
Graphite Bio Inc
196.6M
-1.9x
---
United StatesEVLO
Evelo Biosciences Inc
213.7M
-1.1x
---
United StatesANTX
AN2 Therapeutics Inc
213.8M
0.0x
---
United StatesBMEA
Biomea Fusion Inc
216.4M
-3.0x
---
As of 2022-11-28

Company Information

BioVie Inc. is a clinical-stage company. The Company is developing drug therapies to treat chronic debilitating conditions, including liver disease and neurological and neuro-degenerative disorders and certain cancers. In liver disease, the Company's orphan drug candidate BIV201 (continuous infusion terlipressin) is developed as a future treatment option for patients suffering from ascites and other life-threatening complications of advanced liver cirrhosis caused by nonalcoholic steatohepatitis (NASH), hepatitis, and alcoholism. The Company is also engaged in developing NE3107, an extracellular single-regulated kinase (ERK) inhibitor that selectively reduces neuroinflammation and insulin resistance. NE3107 is an orally administered small molecule to inhibit inflammation-driven insulin resistance and pathological inflammatory cascades.

Contact Information

Headquarters
680 W NYE LANE, SUITE 201CARSON CITY, NV, United States 89703
Phone
775-888-3162
Fax
---

Executives

Chairman of the Board
Terren Peizer
President, Chief Executive Officer, Director
Cuong Do
Chief Financial Officer, Corporate Secretary
Joanne Kim
Executive Vice President - Liver Cirrhosis Programs
Jonathan Adams
Executive Vice President - Product Development
Clarence Ahlem

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$201.8M
Revenue (TTM)
$0.00
Shares Outstanding
30.5M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
2.79
EPS
$-1.21
Book Value
$0.15
P/E Ratio
-5.5x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.